Representation of Adults with CKD in Major Endovascular Stroke Trials

Chronic kidney disease (CKD) and stroke are significant public health concerns, each associated with substantial morbidity and mortality. The risk for stroke increases by an average of 7% with every 10 mL/min/1.73 m2 reduction in glomerular filtration rate1,2, and the impact of CKD on stroke mortality is pronounced, especially among younger individuals and women.3 Advanced CKD is associated with significantly higher odds of in-hospital mortality following stroke. 3